Home / Available CME / Corrections
Credit Designation
Disclosure of Conflicts of Interest
Disclosure of Unlabeled Use
Disclaimer
Instructions for Participation
Antiretroviral Therapy in the Correctional Setting
Jointly sponsored by:
 |
 |
Scroll Down to Review Program Information and Launch Program
About the Program
- Program Overview
- Target Audience
- Acknowledgement of Commercial Support
- Learning Objectives
- Course Directors
- Faculty
- Program Modules
- Post-Module Faculty Teleconference
- Accreditation Statement
- Credit Designation
- Disclosure of Conflicts of Interest
- Disclosure of Unlabeled Use
- Disclaimer
- Instructions for Participation
Program Overview
Due to the large number of FDA-approved antiretrovirals (ARV) and ARV classes, health care providers caring for HIV-positive patients now have multiple choices regarding antiretroviral therapy (ART), even in most patients with significant past ART experience. While these choices provide health care providers and patients with important new options, they also lead to many new challenges. Some of the most important challenges facing HIV health care providers today involve understanding and effectively utilizing the wealth of clinical research data assessing ART choices for ART-naive and ART-experienced patients as well as considering the individual needs of each patient. While all health care providers managing HIV patients face these challenges, those in the correctional setting face many additional issues unique to correctional institutions.
This case-based program has been designed to help health care providers understand and address the universal medical, social, behavioral, and institutional issues involved in providing medical care to HIV-positive patients in a correctional setting. It offers an expert faculty who will explore and discuss the circumstances found in the correctional setting, and provide evidence-based and practical solutions to some of the common problems health care providers confront in that setting. Three online modules will address considerations for 1) The Selection of ART for ART-Naive Patients in the Correctional Setting; 2) Assessing Resistance and Selecting ART Therapy in ART-Experienced Patients in the Correctional Setting; and 3) Addressing the Needs and Improving the Care of HIV-Positive Incarcerated Patients.
Back to Top
Target Audience
This activity has been designed to meet the educational needs of physicians and other health care providers who diagnose and manage patients with HIV/AIDS within the correctional setting.
Back to Top
Acknowledgement of Commercial Support
Supported by an unrestricted educational grant by Bristol-Myers Squibb.
Back to Top
Learning Objectives
Upon completion of the program, participants should be able to:
-
Discuss the key clinical research evaluating ART regimens and strategies;
-
Apply research findings to improve ART success rates including data related to ARV tolerance, adverse events, resistance barriers, pharmacokinetics, and other issues;
-
Manage HIV infection in a corrections setting more effectively;
-
Select ART regimens that maximize each patient's chance of long-term success in the corrections setting.
Back to Top
Course Director
John Bartlett, MD
Professor of Medicine,
Johns Hopkins University School of Medicine
Baltimore, Maryland
Back to Top
Faculty
 |
Frederick L. Altice, MD Professor of Medicine, Director of Clinical and Community Research, Yale University School of Medicine, Section of Infectious Diseases, AIDS Program New Haven, Connecticut |
 |
David Wohl, MD |
Back to Top
Program Modules
1) The Selection of ART for ART-Naive Patients in the Correctional Setting
2) Assessing Resistance and Selecting ART Therapy in ART-Experienced Patients in the Correctional Setting
3) Addressing the Needs and Improving the Care of HIV-Positive Incarcerated Patients
Media: Internet
Release Date: October 29, 2010
Expiration Date: October 28, 2011
Please click button below to launch modules.
Click here to view Participation Instructions.
Back to Top
Post-Module Faculty Teleconference
Upon the completion of 2 of the 3 modules, and passing the corresponding CME post-tests, each participant will have an opportunity to have a 15 minute teleconference with one of the faculty members. The primary purpose of this teleconference will be to answer questions or provide information regarding the completed modules; however, other areas of interest may also be addressed at the discretion of the faculty member. Click the button below to request a teleconference with a faculty member.
Back to Top
Accreditation Statement
This activity has been planned and implemented in accordance with the essential areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Postgraduate Institute for Medicine (PIM) and ViralEd, LLC. PIM is accredited by the ACCME to provide continuing medical education for physicians.
Back to Top
Credit Designation
Postgraduate Institute for Medicine designates each educational activity, or module, for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Back to Top
Disclosure of Conflicts of Interest
The Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships to product devices they or their spouse/life partner have with commercial interests related to the content of this CME activity.
John Bartlett, MD
- Reports no real or apparent conflicts of interest.
Frederick Altice, MD
- Fees for non-CME/CE Services: Bristol-Myers Squibb, Merck, Genentech, Tibotec
- Contracted Research: Boehringer Ingleheim
David Wohl, MD
- Consulting Fees: Abbott, Tibotec, Gilead
- Contracted Research: Merck, GSK, Tibotec, Gilead
- Fees for non-CME/CE Services: Gilead, Abbott, Tibotec, Bristol-Myers Squibb, Merck
The following PIM planners and managers, Jan Hixon, RN, BSN, MA, Trace Hutchison, PharmD, Julia Kirkwood, RN, BSN, Samantha Mattiucci, PharmD, and Jan Schultz, RN, MSN, CCMEP hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
Back to Top
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Postgraduate Institute for Medicine (PIM), ViralEd, LLC and Bristol-Myers Squibb do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, ViralEd, LLC and Bristol-Myers Squibb. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Back to Top
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Back to Top
Instructions for Participation
There are no fees for participating and receiving credit for this activity. During the period, October 28, 2010 through October 27, 2011, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; and 3) complete the post-test and evaluation form.
To answer the questions, click on your selected choice for each answer then proceed to the next question. We recommend that you print a copy of your answers before you submit them to us. Once completed, click on the Submit Post-test at the bottom of the page. Your post-test will automatically be graded.
If you successfully complete the post-test (score of 70% or higher). your certificate will be made available immediately. Click on View Certificate and print the certificate for your records. If you received a score of 69% or less, you will receive a message notifying you that you did not pass the post-test. You may retake the post-test until successful.
You may complete the Post-test on-line at http://www.cmeuniversity.com/.
- Click on "Find Post-Test/Evaluation by Course" on the navigation menu
- Search by Project ID (Module 1: 7575; Module 2: 7578; Module 3: 7577)
- Upon successfully completing the Post-test and Evaluation form, your certificate will be made available immediately.
Share this page:
